IRLAB’s Phase IIb/III study in Parkinson’s disease to target Good ON news.cision.com/irlab-therapeu…

IRLAB’s mesdopetam featured on cover of top-tier publication JPET ​​​​​​​ news.cision.com/irlab-therapeu…

IRLABs mesdopetam presenteras på omslaget av topprankade vetenskapliga tidskriften JPET news.cision.com/se/irlab-thera…

IRLAB’s clinical drug candidate IRL752 published in JPET ​​​​​​​ news.cision.com/irlab-therapeu…

IRLAB:s kliniska läkemedelskandidat IRL752 publicerad i JPET news.cision.com/se/irlab-thera…

IRLAB’s IRL752 is proposed pirepemat as a unique INN by WHO ​​​​​​​ news.cision.com/irlab-therapeu…

IRLABs IRL752 föreslås få det unika INN-namnet pirepemat av WHO news.cision.com/se/irlab-thera…

IRLAB delårsrapport januari – juni 2020 news.cision.com/se/irlab-thera…

IRLAB’s drug candidate pirepemat featured on cover of top-tier journal JPET ​​​​​​​ news.cision.com/irlab-therapeu…

IRLAB:s läkemedelskandidat pirepemat presenteras på omslaget av topprankade vetenskapliga tidskriften JPET news.cision.com/se/irlab-thera…

IRLAB Therapeutics has been approved for listing on Nasdaq Stockholm Main Market news.cision.com/irlab-therapeu…

IRLAB Therapeutics har godkänts för notering på Nasdaq Stockholms huvudlista news.cision.com/se/irlab-thera…

IRLAB offentliggör prospekt i samband med notering på Nasdaq Stockholms huvudlista news.cision.com/se/irlab-thera…

IRLAB publishes prospectus in connection with its listing on Nasdaq Stockholm Main Market news.cision.com/irlab-therapeu…

IRLAB:s aktie handlas från idag på Nasdaq Stockholms huvudlista news.cision.com/se/irlab-thera…

IRLAB's shares are now traded on Nasdaq Stockholm Main Market ​​​​​​​ news.cision.com/irlab-therapeu…

IRLAB's mesdopetam IND accepted by the US FDA news.cision.com/irlab-therapeu…

IRLAB:s ansökan om IND för mesdopetam godkänd av FDA ​​​​​​​ news.cision.com/se/irlab-thera…

Hear first-hand from IRLAB Therapeutics CEO Dr Nicholas Waters and deep dive into how the company is developing novel #drugs to treat #neurodegenerative diseases. 👩‍🔬 $IRLAB #Parkinsons #disease #therapeutics hubs.ly/Q012CM3X0

Look at the full lenght interview with CEO Nicholas Waters on Edison Open House - Global Healthcare 2022. youtube.com/watch?v=L9-J4S…